Protection of the Human Gut Microbiome From Antibiotics/Experiment 2/Signature 1

From BugSigDB
Needs review

Curated date: 2021/01/10

Curator: Mst Afroza Parvin

Revision editor(s): WikiWorks

Source: Supplementary table 3, Supplementary figure 1

Description: A detailed analysis of the MGSs that differed significantly between treatment groups

Abundance in Group 1: increased abundance in DAV132+moxifloxacin treated group (MXF+DAV132)

NCBI Quality ControlLinks
Parabacteroides distasonis
Bilophila wadsworthia
Roseburia inulinivorans
Odoribacter splanchnicus
Lachnospiraceae
Blautia sp.
Clostridium sp.
Bacillota
Faecalibacterium prausnitzii
Ruminococcus callidus
Alistipes shahii
Alistipes
Faecalibacterium
Parasutterella excrementihominis
Cloacibacterium sp.
Bifidobacterium adolescentis
Alistipes onderdonkii
Blautia
Oscillibacter
Oscillibacter sp.
Coprobacillus
Alistipes finegoldii
Butyricimonas virosa
Oscillospiraceae
Eubacteriales
Eubacterium
Alistipes putredinis
Butyricimonas
Barnesiella intestinihominis
Lachnospira eligens
Catenibacterium
Dorea formicigenerans
Haemophilus parainfluenzae
Alistipes senegalensis

Revision editor(s): WikiWorks